The Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a double-blind, randomized controlled trial of metoclopramide for the prevention of pneumonia in patients with dysphagia after an acute stroke

Short title	The Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a double-blind, randomized controlled trial of metoclopramide for the prevention of pneumonia in patients with dysphagia after an acute stroke
Status	Active
Effective start/end date	1/01/21 → 31/12/24

Project Details